CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock |
Beginning balance (in shares) at Jan. 30, 2022 | | | 71,982,000 | | | | |
Beginning balance at Jan. 30, 2022 | | $ 1,664,207 | $ 720 | $ 600,942 | $ 1,074,084 | $ (10,828) | $ (711) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 254,113 | | | 254,113 | | |
Foreign currency translation adjustments | | (1,514) | | | | (1,514) | |
Change in fair value of derivative financial instruments, net of tax | | 93 | | | | 93 | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (18) | | | | (18) | |
Conversion/release of stock-based awards (in shares) | [1] | | 617,000 | | | | |
Conversion/release of stock-based awards | [1] | (78,508) | $ 6 | (78,142) | | | (372) |
Repurchase of common stock (in shares) | | | (3,380,000) | | | | |
Repurchases of common stock | | (501,075) | $ (33) | (18,590) | (482,452) | | |
Reissuance of treasury stock under stock-based compensation plans | [1] | 0 | | (344) | 0 | | 344 |
Stock-based compensation expense | | 28,339 | | 28,339 | | | |
Dividends declared | | (55,893) | | | (55,893) | | |
Ending balance (in shares) at May. 01, 2022 | | | 69,219,000 | | | | |
Ending balance at May. 01, 2022 | | 1,309,744 | $ 693 | 532,205 | 789,852 | (12,267) | (739) |
Beginning balance (in shares) at Jan. 30, 2022 | | | 71,982,000 | | | | |
Beginning balance at Jan. 30, 2022 | | 1,664,207 | $ 720 | 600,942 | 1,074,084 | (10,828) | (711) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 772,911 | | | | | |
Foreign currency translation adjustments | | (8,057) | | | | | |
Change in fair value of derivative financial instruments, net of tax | | 1,188 | | | | | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (151) | | | | | |
Ending balance (in shares) at Oct. 30, 2022 | | | 66,556,000 | | | | |
Ending balance at Oct. 30, 2022 | | 1,412,934 | $ 666 | 553,698 | 877,157 | (17,848) | (739) |
Beginning balance (in shares) at May. 01, 2022 | | | 69,219,000 | | | | |
Beginning balance at May. 01, 2022 | | 1,309,744 | $ 693 | 532,205 | 789,852 | (12,267) | (739) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 267,075 | | | 267,075 | | |
Foreign currency translation adjustments | | (1,385) | | | | (1,385) | |
Change in fair value of derivative financial instruments, net of tax | | 26 | | | | 26 | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (5) | | | | (5) | |
Conversion/release of stock-based awards (in shares) | [1] | | 26,000 | | | | |
Conversion/release of stock-based awards | [1] | (767) | | (767) | | | |
Repurchase of common stock (in shares) | | | (2,188,000) | | | | |
Repurchases of common stock | | (265,349) | $ (22) | (12,519) | (252,808) | | |
Stock-based compensation expense | | 22,976 | | 22,976 | | | |
Dividends declared | | (54,036) | | | (54,036) | | |
Ending balance (in shares) at Jul. 31, 2022 | | | 67,057,000 | | | | |
Ending balance at Jul. 31, 2022 | | 1,278,279 | $ 671 | 541,895 | 750,083 | (13,631) | (739) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 251,723 | | | 251,723 | | |
Foreign currency translation adjustments | | (5,158) | | | | (5,158) | |
Change in fair value of derivative financial instruments, net of tax | | 1,069 | | | | 1,069 | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (128) | | | | (128) | |
Conversion/release of stock-based awards (in shares) | [2] | | 13,000 | | | | |
Conversion/release of stock-based awards | [2] | (1,156) | | (1,156) | | | |
Repurchase of common stock (in shares) | | | (514,000) | | | | |
Repurchases of common stock | | (74,531) | $ (5) | (3,010) | (71,516) | | |
Stock-based compensation expense | | 15,969 | | 15,969 | | | |
Dividends declared | | (53,133) | | | (53,133) | | |
Ending balance (in shares) at Oct. 30, 2022 | | | 66,556,000 | | | | |
Ending balance at Oct. 30, 2022 | | 1,412,934 | $ 666 | 553,698 | 877,157 | (17,848) | (739) |
Beginning balance (in shares) at Jan. 29, 2023 | | | 66,226,000 | | | | |
Beginning balance at Jan. 29, 2023 | | 1,701,051 | $ 663 | 573,117 | 1,141,819 | (13,809) | (739) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 156,531 | | | 156,531 | | |
Foreign currency translation adjustments | | (2,205) | | | | (2,205) | |
Change in fair value of derivative financial instruments, net of tax | | 242 | | | | 242 | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (486) | | | | (486) | |
Conversion/release of stock-based awards (in shares) | [2] | | 498,000 | | | | |
Conversion/release of stock-based awards | [2] | (49,518) | $ 5 | (49,322) | | | (201) |
Repurchase of common stock (in shares) | [3] | | (2,502,000) | | | | |
Repurchases of common stock | [3] | (302,401) | $ (25) | (14,803) | (286,573) | | (1,000) |
Reissuance of treasury stock under stock-based compensation plans | [2] | 0 | | (334) | (180) | | 514 |
Stock-based compensation expense | | 23,282 | | 23,282 | | | |
Dividends declared | | (59,671) | | | (59,671) | | |
Ending balance (in shares) at Apr. 30, 2023 | | | 64,222,000 | | | | |
Ending balance at Apr. 30, 2023 | | 1,466,825 | $ 643 | 531,940 | 951,926 | (16,258) | (1,426) |
Beginning balance (in shares) at Jan. 29, 2023 | | | 66,226,000 | | | | |
Beginning balance at Jan. 29, 2023 | | 1,701,051 | $ 663 | 573,117 | 1,141,819 | (13,809) | (739) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 595,323 | | | | | |
Foreign currency translation adjustments | | (4,062) | | | | | |
Change in fair value of derivative financial instruments, net of tax | | 163 | | | | | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (896) | | | | | |
Ending balance (in shares) at Oct. 29, 2023 | | | 64,135,000 | | | | |
Ending balance at Oct. 29, 2023 | | 1,813,234 | $ 642 | 572,406 | 1,260,216 | (18,604) | (1,426) |
Beginning balance (in shares) at Apr. 30, 2023 | | | 64,222,000 | | | | |
Beginning balance at Apr. 30, 2023 | | 1,466,825 | $ 643 | 531,940 | 951,926 | (16,258) | (1,426) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 201,507 | | | 201,507 | | |
Foreign currency translation adjustments | | 2,171 | | | | 2,171 | |
Change in fair value of derivative financial instruments, net of tax | | (157) | | | | (157) | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (296) | | | | (296) | |
Conversion/release of stock-based awards (in shares) | [2] | | 13,000 | | | | |
Conversion/release of stock-based awards | [2] | (432) | | (432) | | | |
Repurchase of common stock (in shares) | [3] | | (90,000) | | | | |
Repurchases of common stock | [3] | (10,096) | $ (1) | (548) | (9,547) | | |
Stock-based compensation expense | | 20,547 | | 20,547 | | | |
Dividends declared | | (59,114) | | | (59,114) | | |
Ending balance (in shares) at Jul. 30, 2023 | | | 64,145,000 | | | | |
Ending balance at Jul. 30, 2023 | | 1,620,955 | $ 642 | 551,507 | 1,084,772 | (14,540) | (1,426) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 237,285 | | | 237,285 | | |
Foreign currency translation adjustments | | (4,028) | | | | (4,028) | |
Change in fair value of derivative financial instruments, net of tax | | 78 | | | | 78 | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (114) | | | | (114) | |
Conversion/release of stock-based awards (in shares) | [2] | | 11,000 | | | | |
Conversion/release of stock-based awards | [2] | (1,159) | | (1,159) | | | |
Repurchase of common stock (in shares) | | | (21,000) | | | | |
Repurchases of common stock | | (3,014) | $ 0 | (131) | (2,883) | | |
Stock-based compensation expense | | 22,189 | | 22,189 | | | |
Dividends declared | | (58,958) | | | (58,958) | | |
Ending balance (in shares) at Oct. 29, 2023 | | | 64,135,000 | | | | |
Ending balance at Oct. 29, 2023 | | $ 1,813,234 | $ 642 | $ 572,406 | $ 1,260,216 | $ (18,604) | $ (1,426) |
| |
[1]Amounts are shown net of shares withheld for employee taxes[2]Amounts are shown net of shares withheld for employee taxes.[3]Repurchases of common stock include accrued excise taxes of $2.5 million as of October 29, 2023, which is recorded in retained earnings. | |